This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
A Baker , S Bucci , TJ Lewin , F Kay-Lambkin , PM Constable , VJ Carr (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: randomised controlled trial. British Journal of Psychiatry 188, 439–448.
C Barrowclough , G Haddock , N Tarrier , SW Lewis , J Moring , R O'Brien , N Schofield , J McGovern (2001). Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry
C Barrowclough , G Haddock , T Wykes , R Beardmore , P Conrod , T Craig , L Davies , G Dunn , E Eisner , S Lewis , J Moring , C Steel , N Tarrier (2010). Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. British Medical Journal 341, c6325.
AS Bellack , ME Bennett , JS Gearon , CH Brown , Y Yang (2006). A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry
G Bersani , V Orlandi , S Gherardelli , P Pancheri (2002). Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology. Psychopathology
C Bonsack , MS Gibellini , J Favrod , Y Montagrin , J Besson , P Bovet , P Conus (2011). Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial. Psychotherapy and Psychosomatics 80, 287–297.
CR Bowie , PD Harvey (2006). Administration and interpretation of the Trail Making Test. Nature Protocols
J Brandt (1991). The Hopkins verbal learning test: development of a new memory test with six equivalent forms. Clinical Neuropsychologist 5, 125–142.
R Brooks (1996). EuroQol: the current state of play. Health Policy
D Caspari (1999). Cannabis and schizophrenia: results of a follow-up study. European Archives of Psychiatry and Clinical Neuroscience 249, 45–49.
M Cleary , G Hunt , S Matheson , N Siegfried , G Walter (2008). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews. Issue 1, Art. No. CD001088.
WM Compton , BF Grant , JD Colliver , MD Glantz , FS Stinson (2004). Prevalence of marijuana use disorders in the United States. Journal of the American Medical Association 291, 2114–2121.
BA Cornblatt , MF Lenzenweger , L Erlenmeyer-Kimling (1989). The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Research 29, 65–85.
DC D'Souza , WM Abi-Saab , S Madonick , K Forselius-Bielen , A Doersch , G Braley , R Gueorguieva , TB Cooper , JH Krystal (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry 57, 594–608.
J Edwards , K Elkins , M Hinton , SM Harrigan , K Donovan , O Athanasopoulos , PD McGorry (2006). Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatrica Scandinavica
J Endicott , RL Spitzer , JL Fleiss , J Cohen (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33, 766–771.
A Grech , J van Os , PB Jones , SW Lewis , RM Murray (2005). Cannabis use and outcome of recent onset psychosis. European Psychiatry
B Green , R Young , D Kavanagh (2005). Cannabis use and misuse prevalence among people with psychosis. British Journal of Psychiatry
RW Heinrichs , KK Zakzanis (1998). Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12, 426–445.
L Hides , S Dawe , DJ Kavanagh , RM Young (2006). Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. British Journal of Psychiatry 189, 137–143.
C Hjorthøj , A Fohlmann , A-M Larsen , MT Madsen , L Vesterager , C Gluud , MC Arendt , M Nordentoft (2008). Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials
C Hjorthøj , A Fohlmann , M Nordentoft (2009). Treatment of cannabis use disorders in people with schizophrenia spectrum disorders – a systematic review. Addictive Behaviors 34, 520–525.
CR Hjorthøj , AR Hjorthøj , M Nordentoft (2012 b). Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances – systematic review and meta-analysis. Addictive Behaviors 37, 225–233.
JM Jerrell , MS Ridgely (1995). Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease
M Kamali , BD Kelly , M Clarke , S Browne , M Gervin , A Kinsella , A Lane , C Larkin , E O'Callaghan (2006). A prospective evaluation of adherence to medication in first episode schizophrenia. European Psychiatry
DJ Kavanagh , R Young , A White , JB Saunders , J Wallis , N Shockley , L Jenner , A Clair (2004). A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review
SR Kay , A Fiszbein , LA Opler (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin
RSE Keefe , TE Goldberg , PD Harvey , JM Gold , MP Poe , L Coughenour (2004). The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research
R Kemp , A Harris , E Vurel , T Sitharthan (2007). Stop Using Stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry
DL Larsen , CC Attkisson , WA Hargreaves , TD Nguyen (1979). Assessment of client/patient satisfaction: development of a general scale. Evaluation and Program Planning 2, 197–207.
VC Leeson , I Harrison , MA Ron , TRE Barnes , EM Joyce (2012). The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophrenia Bulletin 38, 873–880.
S Martino , KM Carroll , C Nich , BJ Rounsaville (2006). A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction
HE Nelson , A O'Connell (1978). Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14, 234–244.
M Nordentoft , HC Knudsen , B Jessen-Petersen , A Krasnik , H Sælan , P Treufeldt , B Wetcher (1996). CCPP – Copenhagen Community Psychiatric Project. Implementation of community mental health centres in Copenhagen: effects of service utilization, social integration, quality of life and positive and negative symptoms. Social Psychiatry and Psychiatric Epidemiology
M Olfson , D Mechanic , S Hansell , CA Boyer , J Walkup , PJ Weiden (2000). Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services 51, 216–222.
L Petersen , P Jeppesen , A Thorup , MB Abel , J Ohlenschlaeger , TO Christensen , G Krarup , P Jorgensen , M Nordentoft (2005). A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. British Medical Journal
S Priebe , P Huxley , S Knight , S Evans (1999). Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry
D Schofield , C Tennant , L Nash , L Degenhardt , A Cornish , C Hobbs , G Brennan (2006). Reasons for cannabis use in psychosis. Australian and New Zealand Journal of Psychiatry 40, 570–574.
KF Schulz , DG Altman , D Moher (2010
a). CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. British Medical Journal
KF Schulz , DG Altman , D Moher , D Fergusson (2010
b). CONSORT 2010 changes and testing blindness in RCTs. Lancet
LC Sobell , MB Sobell (1992). Timeline follow-back: a technique for assessing self-reported alcohol consumption. In Measuring Alcohol Consumption: Psychosocial and Biological Methods (ed. R. Z. Litten and J. Allen ), pp. 41–72. Humana Press: New Jersey.
J van Os , M Bak , M Hanssen , RV Bijl , R de Graaf , H Verdoux (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319–327.
AM Weinstein , DA Gorelick (2011). Pharmacological treatment of cannabis dependence. Current Pharmaceutical Design 17, 1351–1358.
JK Wing , T Babor , T Brugha , J Burke , JE Cooper , R Giel , A Jablenski , D Regier , N Sartorius (1990). SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 47, 589–593.
M Yücel , E Bora , DI Lubman , N Solowij , WJ Brewer , SM Cotton , P Conus , MJ Takagi , A Fornito , SJ Wood , PD McGorry , C Pantelis (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin